Clinical trial
Anecortave Acetate Risk Reduction Trial (AART)
NCT00332657 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anecortave Acetate Risk Reduction Trial (AART)
- Lead sponsor
- Alcon Research
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 2006
- Completion date
- December 31, 2008
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amd